Greater baseline EASI scores and greater BMI are associated with poor response to lebrikizumab among patients with moderate to severe AD.
An artificial intelligence (AI) algorithm can predict progression of keratoconus, according to a study presented at the annual Congress of the European Society of Cataract and Refractive Surgeons, ...